Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumorsJian Li, Lin Shen, Yunong Gao et al.|Chinese Journal of Cancer Research|2024Cited by 18